| A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis L Dupuis, R Dengler, MT Heneka, T Meyer, S Zierz, J Kassubek, ... PloS one 7 (6), e37885, 2012 | 152 | 2012 |
| A phase II− III trial of olesoxime in subjects with amyotrophic lateral sclerosis T Lenglet, L Lacomblez, JL Abitbol, A Ludolph, JS Mora, W Robberecht, ... European journal of neurology 21 (3), 529-536, 2014 | 134 | 2014 |
| Safety and effectiveness of long-term intravenous administration of edaravone for treatment of patients with amyotrophic lateral sclerosis S Witzel, A Maier, R Steinbach, J Grosskreutz, JC Koch, A Sarikidi, S Petri, ... JAMA neurology 79 (2), 121-130, 2022 | 103* | 2022 |
| Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial A Maier, T Holm, P Wicks, L Steinfurth, P Linke, C Münch, R Meyer, ... Amyotrophic Lateral Sclerosis 13 (2), 210-216, 2012 | 90 | 2012 |
| Severe loss of appetite in amyotrophic lateral sclerosis patients: online self-assessment study T Holm, A Maier, P Wicks, D Lang, P Linke, C Münch, L Steinfurth, ... Interactive journal of medical research 2 (1), e2463, 2013 | 68 | 2013 |
| Interleukin-1 antagonist anakinra in amyotrophic lateral sclerosis—a pilot study A Maier, N Deigendesch, K Müller, JH Weishaupt, A Krannich, R Röhle, ... PLoS One 10 (10), e0139684, 2015 | 61 | 2015 |
| Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol: cannabidiol (THC: CBD) T Meyer, A Funke, C Münch, D Kettemann, A Maier, B Walter, A Thomas, ... BMC neurology 19, 1-13, 2019 | 55 | 2019 |
| Awareness challenges of mental health disorder and dementia facing stigmatisation and discrimination: a systematic literature review from Sub-Sahara Africa S Spittel, A Maier, E Kraus Journal of global health 9 (2), 2019 | 47 | 2019 |
| Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach A Funke, S Spittel, T Grehl, J Grosskreutz, D Kettemann, S Petri, U Weyen, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19 (5-6), 342-350, 2018 | 44 | 2018 |
| De novo partial deletion in GRID2 presenting with complicated spastic paraplegia A Maier, E Klopocki, D Horn, A Tzschach, T Holm, R Meyer, T Meyer Muscle & nerve 49 (2), 289-292, 2014 | 41 | 2014 |
| Patient-reported outcome of physical therapy in amyotrophic lateral sclerosis: observational online study R Meyer, S Spittel, L Steinfurth, A Funke, D Kettemann, C Münch, T Meyer, ... JMIR rehabilitation and assistive technologies 5 (2), e10099, 2018 | 40 | 2018 |
| Electronic data capture in healthcare—NFC as easy way for self-reported health status information A Prinz, P Menschner, JM Leimeister Health Policy and Technology 1 (3), 137-144, 2012 | 36 | 2012 |
| Thalidomide causes sinus bradycardia in ALS T Meyer, A Maier, N Borisow, JS Dullinger, G Splettstößer, S Ohlraun, ... Journal of neurology 255, 587-591, 2008 | 35 | 2008 |
| Non‐invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany S Spittel, A Maier, D Kettemann, B Walter, B Koch, K Krause, J Norden, ... European Journal of Neurology 28 (4), 1160-1171, 2021 | 34* | 2021 |
| Clinical characteristics and course of dying in patients with amyotrophic lateral sclerosis withdrawing from long-term ventilation D Kettemann, A Funke, A Maier, S Rosseau, R Meyer, S Spittel, C Münch, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18 (1-2), 53-59, 2017 | 29 | 2017 |
| Con: Der freiwillige Verzicht auf Nahrung und Flüssigkeit ist keine Form des Suizids B Alt-Epping Zeitschrift für Palliativmedizin 19 (01), 12-15, 2018 | 25 | 2018 |
| Characterization of diplopia in non-demented patients with Parkinson's disease KA Schindlbeck, S Schönfeld, W Naumann, DJ Friedrich, A Maier, ... Parkinsonism & related disorders 45, 1-6, 2017 | 24 | 2017 |
| Disturbance of verticality perception and postural dysfunction in Parkinson's disease KA Schindlbeck, W Naumann, A Maier, F Ehlen, F Marzinzik, ... Acta Neurologica Scandinavica 137 (2), 212-217, 2018 | 23 | 2018 |
| Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen T Meyer, A Maier, Z Uzelac, T Hagenacker, R Günther, O Schreiber‐Katz, ... European journal of neurology 28 (8), 2582-2595, 2021 | 20 | 2021 |
| Neurofilament light‐chain response during therapy with antisense oligonucleotide Tofersen in sod1‐related als: treatment experience in clinical practice T Meyer, P Schumann, P Weydt, S Petri, Y Koc, S Spittel, S Bernsen, ... Muscle & Nerve 67 (6), 515-521, 2023 | 19 | 2023 |
Julian GrosskreutzPrecision Neurology, University of LübeckVerified email at neuro.uni-luebeck.de
